Back to Selection     Print       Date : 31 Oct 2025
Fund Summary
UTI Healthcare Fund (G)
[Equity: Sectoral]  
 
Fund Details
Fund Type Growth Launch Date 28-Jun-99
Corpus(Cr.) 1125.0 Latest NAV 287.9983 As on 05-12-2025
Equity(%) 98.12 52 Week High 299.714
Debt(%) 1.88 52 Week Low 247.991
Others(%) 0.0 Exit Load 1% for redemption within 30 days
Minimum Investment - Availability
Entry Load Nil Expense Ratio(%) 2.26
Scheme Benchmark BSE Healthcare TRI Broader Benchmark NSE - Nifty 50 TRI
Fund Manager Kamal Gada
 
Riskometer
Investors understand that their principal will be at Very High risk
 
Scheme Objective
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector.

Portfolio Classification
 
Asset Mix
 
Concentration Analysis
Top 5 Holdings 29.46%
Top 10 Holdings 47.49%
Top 25 Holdings 81.66%
 
Sector Analysis
Sector/Ratings Net Asset(%)
Pharma & Biotech 75.29
Healthcare 22.83
Cash 1.87
Others 0.01
 
 
 
 
 
Portfolio Metrics
PB Ratio 5.60
PE Ratio 39.36
 
Top 25 Holdings
Holdings Net Asset(%)
Sun Pharmaceutical Industries Limited 9.77
Ajanta Pharma Limited 6.25
Lupin Limited 5.58
Glenmark Pharmaceuticals Limited 4.12
Cipla Limited 3.74
Procter & Gamble Health Limited 3.67
Gland Pharma Limited 3.65
Apollo Hospitals Enterprise Limited 3.62
Dr Reddys Laboratories Limited 3.57
Alkem Laboratories Limited 3.52
EQ- JUPITER LIFE LINE HOSPITALS LTD 3.20
DIVI LABORATORIES LTD 2.99
Fortis Health Care Ltd 2.55
Eris Lifesciences Limited 2.54
Aurobindo Pharma Limited 2.53
Max Healthcare Institute Limited 2.45
Cohance Lifesciences Limited 2.41
Caplin Point Laboratories Limited 2.36
Krishna Inst of Medical Sciences Ltd. 2.26
NET CURRENT ASSETS 1.87
Sai Life Sciences Limited 1.87
Aster DM Healthcare Limited 1.84
Pfizer Limited 1.79
IPCA Laboratories Limited 1.78
EQ- GLOBAL HEALTH LTD. 1.73

Performance Analysis
 
Short Terms Returns
1 Month 3 Month 6 Month 1 Year
-0.94% -1.75% 2.97% -0.97%
 
Broader Market Benchmark [NSE - Nifty 50 TRI]
2.70% 6.00% 5.46% 7.43%
 
Scheme Benchmark [BSE Healthcare TRI]
 
Long term Returns
2 Year 3 Year 5 Year 10 Year
20.51% 23.67% 15.98% 11.94%
 
 
13.19% 13.29% 15.94% 14.28%
 
 
 
Cumulative Performance of Last 5 Years
 
Calendar Year Returns

Risk Analysis
 
Absolute Metrics (Single Computation - last 3 years)
Scheme Name Standard Deviation Sharpe Ratio Downside Deviation Downside Probability Sortino Ratio
UTI Healthcare Fund (G) 15.78% 1.1664 10.4150% 43.9783 0.1571
 
Benchmark Relative Metrics (Single Computation - last 3 years)
Scheme Name Alpha Beta Treynor Ratio Tracking Error Information Ratio
UTI Healthcare Fund (G) 13.5777% 0.0002 0.3109 14.0734 0.9405
 
Back to Selection